AU6093794A - Wound healing composition - Google Patents

Wound healing composition

Info

Publication number
AU6093794A
AU6093794A AU60937/94A AU6093794A AU6093794A AU 6093794 A AU6093794 A AU 6093794A AU 60937/94 A AU60937/94 A AU 60937/94A AU 6093794 A AU6093794 A AU 6093794A AU 6093794 A AU6093794 A AU 6093794A
Authority
AU
Australia
Prior art keywords
igf
igfbp
pharmaceutical composition
wound
ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60937/94A
Other languages
English (en)
Inventor
George N. Cox
Thomas A Mustoe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Boulder Inc
Original Assignee
Synergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synergen Inc filed Critical Synergen Inc
Publication of AU6093794A publication Critical patent/AU6093794A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU60937/94A 1993-01-29 1994-01-25 Wound healing composition Abandoned AU6093794A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1103193A 1993-01-29 1993-01-29
US011031 1993-01-29
PCT/US1994/000799 WO1994016723A2 (en) 1993-01-29 1994-01-25 Wound healing composition

Publications (1)

Publication Number Publication Date
AU6093794A true AU6093794A (en) 1994-08-15

Family

ID=21748560

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60937/94A Abandoned AU6093794A (en) 1993-01-29 1994-01-25 Wound healing composition

Country Status (8)

Country Link
EP (1) EP0686040A1 (ja)
JP (1) JPH09500088A (ja)
KR (1) KR960700069A (ja)
AU (1) AU6093794A (ja)
CA (1) CA2154078A1 (ja)
FI (1) FI953615L (ja)
NO (1) NO952987L (ja)
WO (1) WO1994016723A2 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062277A1 (en) * 2000-02-25 2001-08-30 Gropep Limited Treatment for peripheral sensory neuropathy

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM678294A0 (en) * 1994-07-13 1994-08-04 Gropep Pty Ltd Use of insulin-like growth factor in combination with insulin
ES2293137T3 (es) * 1995-10-11 2008-03-16 Novartis Vaccines And Diagnostics, Inc. Combinacion de pdgf, kgf,igf e igfbp para curacion de heridas.
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
US20030069177A1 (en) 2000-05-16 2003-04-10 Genentech, Inc. Method for treating cartilage disorders
CA2356109C (en) 1999-01-06 2008-04-22 Genentech, Inc. Insulin-like growth factor (igf) i mutant variants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341598C (en) * 1988-07-15 2009-09-29 Central Sydney Area Health Service Acid-labile sub-unit (als) of insulin-like growth factor binding proteincomplex
DE69132814T2 (de) * 1990-08-28 2002-06-13 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Neues insulinähnliches wachstumsfaktor bindendes protein igfbp-5
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
ES2174852T3 (es) * 1992-08-26 2002-11-16 Celtrix Pharma Metodo para el tratamiento sistemico de estados catabolicos y lesiones sistemicas de tejidos.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062277A1 (en) * 2000-02-25 2001-08-30 Gropep Limited Treatment for peripheral sensory neuropathy

Also Published As

Publication number Publication date
FI953615A7 (fi) 1995-07-28
WO1994016723A2 (en) 1994-08-04
JPH09500088A (ja) 1997-01-07
KR960700069A (ko) 1996-01-19
EP0686040A1 (en) 1995-12-13
WO1994016723A3 (en) 1994-09-15
NO952987D0 (no) 1995-07-27
NO952987L (no) 1995-08-30
FI953615A0 (fi) 1995-07-28
CA2154078A1 (en) 1994-08-04
FI953615L (fi) 1995-07-28

Similar Documents

Publication Publication Date Title
Rothe et al. Growth factors: their biology and promise in dermatologic diseases and tissue repair
US5814605A (en) Therapeutic uses of keratinocyte growth factor
AU707340B2 (en) Therapeutic uses of keratinocyte growth factor
AU565347B2 (en) Repair of tissue in animals
JPH0611709B2 (ja) 角膜基質創傷の治療のための組成物
EP0559769B1 (en) Heparin binding mitogen with homology to epidermal growth factor (egf)
JP2001526239A (ja) 角質細胞増殖因子−２製剤
WO1994012219A2 (en) Modified insulin-like growth factors
JPH06505983A (ja) 創傷治癒の促進方法および促進薬
BR122020010515B1 (pt) Peptídeo tendo uma atividade de um fator de crescimento (gf) e derivado de gf e composição farmacêutica para aperfeiçoamento de uma condição de pele e para o tratamento de um ferimento
WO2002043751A1 (en) Use of insulin containing composition for wound treatment
US6767891B2 (en) Peptides with wound healing activity
JP2025125558A (ja) 皮膚科障害の処置のための薬剤
WO1994016723A2 (en) Wound healing composition
WO1993019084A1 (en) Refolding and purification of insulin-like growth factor i
AU2003234066A1 (en) Muteins of placental growth factor type 1, preparation method and application thereof
JP3931353B2 (ja) 創傷治癒剤
JPH07316066A (ja) 創傷治癒剤
JPWO1995007710A1 (ja) 創傷治療剤
EP0669134A1 (en) Remedy for wound
CN100334114C (zh) 一种新型融合蛋白及其制备
US7807178B2 (en) Muteins of placental growth factor type I, preparation method and application thereof
JPH0912478A (ja) 新規な皮膚欠損症治療剤
HK1014031A (en) Keratinocyte growth factor (kgf) for its use in method of therapeutic treatment for the human or animal body